Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 353

1.

Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.

Yang Z, Xu L, Liu L, Feng Q, Zhang L, Ma W, Saldanha J, Wang M, Zhao L.

Transfusion. 2013 Oct;53(10 Pt 2):2538-44. doi: 10.1111/trf.12159. Epub 2013 Mar 11.

PMID:
23480568
2.

Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.

Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.

Transfus Apher Sci. 2009 Aug;41(1):3-7. doi: 10.1016/j.transci.2009.05.001. Epub 2009 May 31.

PMID:
19487161
3.

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.

Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.

Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.

PMID:
18422856
4.

Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.

Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J.

Transfusion. 2008 Sep;48(9):1853-61. doi: 10.1111/j.1537-2995.2008.01779.x. Epub 2008 May 29.

PMID:
18513254
5.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
6.

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.

Transfusion. 2012 Feb;52(2):440-6. doi: 10.1111/j.1537-2995.2011.03283.x. Epub 2011 Aug 2.

PMID:
21810101
8.

Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test.

Lin KT, Chang CL, Tsai MH, Lin KS, Saldanha J, Hung CM.

Vox Sang. 2014 Feb;106(2):103-10. doi: 10.1111/vox.12075. Epub 2013 Aug 2.

PMID:
23909571
9.

Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.

Japanese Red Cross NAT Screening Research Group.

Jpn J Infect Dis. 2000 Jun;53(3):116-23. Erratum in: Jpn J Infect Dis 2000 Oct;53(5):219.

PMID:
10957709
10.

Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.

Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M.

J Infect. 2009 Aug;59(2):128-33. doi: 10.1016/j.jinf.2009.06.007. Epub 2009 Jun 18.

PMID:
19586663
11.

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.

Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C; Working Group for NAT Study in Thai Blood Donations.

Transfusion. 2009 Jun;49(6):1126-35. doi: 10.1111/j.1537-2995.2009.02176.x. Epub 2009 Apr 21.

PMID:
19392770
12.

[Evaluation of multiplex nucleic acid testing assays for screening of hepatitis B virus DNA in blood donation process].

Zhou C, Wu X, Huang WJ, Lan HY, Gu WJ, Qi ZB, Liang ZL, Li HM.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Dec;29(12):1240-2. Chinese.

PMID:
19173972
13.

HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.

Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.

J Clin Virol. 2007 Aug;39(4):282-7. Epub 2007 Jul 5.

PMID:
17611148
14.

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.

Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.

Transfusion. 2005 Aug;45(8):1247-57.

PMID:
16078909
15.

Comparative analysis of triplex nucleic acid test assays in United States blood donors.

Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH.

Transfusion. 2013 Oct;53(10 Pt 2):2525-37. doi: 10.1111/trf.12178. Epub 2013 Apr 3.

16.
17.

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

Busch MP.

Transfus Clin Biol. 2004 Feb;11(1):26-32. Review.

PMID:
14980546
18.
19.

Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.

Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.

Transfusion. 2007 Oct;47(10):1794-802.

PMID:
17880603
20.

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.

Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP; REDS Study Group.

Transfusion. 2004 Sep;44(9):1332-9.

PMID:
15318857

Supplemental Content

Support Center